Kathryn Flynn, PhD
Professor, Vice Chair for Research
Locations
- Department of Medicine
Division of Hematology and Oncology
Biography
Dr. Kathryn Flynn is the Georgia Carroll Professor of Women's Health Research in the Division of Hematology and Oncology. She is the Vice Chair for Research for the Department of Medicine and the Scientific Director for Patient-Reported Outcomes in the Center for International Blood and Marrow Transplant Research (CIBMTR). She was trained in sociology (BA, MS) and population health sciences (PhD).
Leadership Positions
- Scientific Director for Patient-Reported Outcomes Center for International Blood and Marrow Transplant Research
- Vice Chair for Research, Department of Medicine
Research Interests
Dr. Flynn conducts clinical and observational research in oncology and women’s health. This includes patient-reported outcome measure development and analysis as well as mixed methods approaches to understanding and improving patient-provider communication and patient decision making. She was a co-investigator in the PROMIS Network – the NIH Roadmap initiative to standardize patient-reported outcomes measurement across diseases. Dr. Flynn was a founding member of the H. Jean Khoury Cure CML Consortium and co-led the 14-site NCI R01-funded LAST study, which examined clinical and patient-reported outcomes among patients with chronic myeloid leukemia who discontinue targeted therapies. She currently co-leads the NCI R01-funded SyMPTOM trial, a randomized trial to improve adherence to daily adjuvant endocrine therapy among women with breast cancer using patient-reported symptom data and clinical pharmacist support to manage symptoms.
Publications
-
(Burek AG, Butler K, Liljestrom T, Weber E, Endres G, Stutzman L, Porada K, Mohammed A, Severson HE, Flynn KE, Ullman A, Davis MBH.) J Hosp Med. 2026 Sep;21(9):1035-1046 PMID: 42543878 PMCID: PMC13534897 SCOPUS ID: 2-s2.0-105046427626 08/03/2026
-
(Flynn KE, Atallah E.) Haematologica. 2026 Jul 01;111(7):2281-2290 PMID: 41376566 PMCID: PMC13317834 SCOPUS ID: 2-s2.0-105044670985 12/11/2025
-
(Palatnik A, Balza J, Akinola I, Yee LM, Peterson Z, Flynn KE.) Am J Perinatol. 2026 Jun;43(8):1059-1065 PMID: 41985493 SCOPUS ID: 2-s2.0-105039065292 04/16/2026
-
The LURN Study-What Have We LURNed So Far?
(Lai HH, LURN Study Group.) Neurourol Urodyn. 2026 Apr;45(4):654-661 PMID: 41944009 SCOPUS ID: 2-s2.0-105035036305 04/07/2026
-
(Awoyinka I, Sheean P, Papanek P, Flynn KE, Bylow K, Kilari D, Gann P, Banerjee A, Stolley M.) Contemp Clin Trials. 2026 Feb;161:108205 PMID: 41453520 PMCID: PMC12987546 SCOPUS ID: 2-s2.0-105027232337 12/27/2025
-
(Cusatis R, Kapfhammer M, Rein L, Szabo A, Reed-Thryselius S, Phelan R, Bingen K, Runaas L, Shaw BE, Flynn KE.) J Cancer Surviv. 2026 Jan 09 PMID: 41511743 PMCID: PMC13044967 SCOPUS ID: 2-s2.0-105027391304 01/09/2026
-
(Neuman HB, Hanlon BM, Breuer C, Stalter LN, McKinney G, Commers W, Kwekkeboom KL, Flynn KE, Haine JE, Schumacher JR.) Journal of Clinical Oncology. June 2026;44:1669-1669 SCOPUS ID: 2-s2.0-105041934488 06/01/2026
-
Lead Service Lines and Infant Blood Lead Levels.
(Balza J, Dawson AZ, Nelson D, Kaeppler C, Cusatis R, Flynn KE.) JAMA Netw Open. 2025 Dec 01;8(12):e2550444 PMID: 41405888 PMCID: PMC12712725 SCOPUS ID: 2-s2.0-105025062251 12/17/2025
-
Expert consensus definition of treatment intolerance in chronic myeloid leukemia in chronic phase.
(Atallah E, Broder MS, Chan O, Flynn KE, Gilreath JA, Hine M, Hunter AM, Mattson HTD, Mauro MJ, Pinilla-Ibarz J, Rein LAM, Stemper E, Tantravahi S, Yang J, Shah NP.) Hematology. 2025 Dec;30(1):2556506 PMID: 41054963 SCOPUS ID: 2-s2.0-105017950500 10/07/2025
-
(Flynn KE, Saini L, Kataria A, Jadhav K, Yang D, Wei D.) Curr Hematol Malig Rep. 2025 Oct 15;20(1):15 PMID: 41091327 PMCID: PMC12528340 SCOPUS ID: 2-s2.0-105018652034 10/15/2025
-
(Boehm D, Smith AR, Mansfield SA, Flynn KE, Fantus RJ, Glaser AP, Helfand BT, Helmuth M, Morgan TN, Lai HH, Sarma AV, Yang CC, Kirkali Z, Griffith JW.) Transl Androl Urol. 2025 Aug 30;14(8):2207-2217 PMID: 40949459 PMCID: PMC12433021 09/15/2025
-
(Balza JS, Awoyinka I, Cusatis R, Dawson AZ, Nelson D, Kaeppler C, Flynn KE.) Discover Public Health. December 2025;22(1) SCOPUS ID: 2-s2.0-105024089890 12/01/2025